Out-patient treatment of acute deep vein thrombosis.

No abstract is available for this paper.

• Publication year

  1998

• Venue

  International Angiology

• Publication date

  1998-09-01

• Fields of study

  Medicine

• Identifiers
  PMID 9821026
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Dose adjusted heparin treatment of deep venous thrombosis: a comparison of unfractionated and low molecular weight heparin

  2004cited by this paper
• A comparison of low-molecular-weight heparin administered primarily at home with unfractionated heparin administered in the hospital for proximal deep-vein thrombosis.

  1996cited by this paper
• Treatment of venous thrombosis with intravenous unfractionated heparin administered in the hospital as compared with subcutaneous low-molecular-weight heparin administered at home. The Tasman Study Group.

  1996cited by this paper
• Comparison of Once-Daily Subcutaneous Fragmin® with Continuous Intravenous Unfractionated Heparin in the Treatment of Deep Vein Thrombosis

  1994cited by this paper
• Antithrombotic therapy for venous thromboembolism.

  1993cited by this paper
• Subcutaneous low-molecular-weight heparin compared with continuous intravenous unfractionated heparin in the treatment of proximal deep vein thrombosis.

  1993cited by this paper
• A prospective study of the incidence of deep‐vein thrombosis within a defined urban population

  1992cited by this paper
• Subcutaneous low-molecular-weight heparin compared with continuous intravenous heparin in the treatment of proximal-vein thrombosis.

  1992cited by this paper
• Comparison of subcutaneous low-molecular-weight heparin with intravenous standard heparin in proximal deep-vein thrombosis.

  1992cited by this paper
• Heparin Binding to Plasma Proteins, an Important Mechanism for Heparin Resistance

  1992cited by this paper
• The Antithrombotic Activity and Pharmacokinetics of Enoxaparine, A Low Molecular Weight Heparin, In Humans Given Single Subcutaneous Doses of 20 to 80 mg

  1988cited by this paper
• Safety and efficacy of warfarin started early after submassive venous thrombosis or pulmonary embolism.

  1986cited by this paper

• Towards evidence-based emergency medicine: best BETs from the Manchester Royal Infirmary

  2017cites this paper
• Towards evidence-based emergency medicine: best BETs from the Manchester Royal Infirmary

  2016cites this paper
• Deep vein thrombosis: who still needs to be admitted?

  2013cites this paper
• [Outpatient management of patients with deep vein thrombosis and cancer: a study of safety, cost and budget impact].

  2012cites this paper
• Modest response in translation to home management of deep venous thrombosis.

  2010cites this paper
• Update Angiologie

  2009cites this paper
• Thromboses veineuses des membres inférieurs

  2006cites this paper
• Treatment of deep vein thrombosis: what factors determine appropriate treatment?

  2005cites this paper
• Outpatient treatment of venous thromboembolism using low molecular weight heparins. An overview.

  2004cites this paper
• Towards evidence based emergency medicine: best BETs from the Manchester Royal Infirmary

  2004cites this paper
• MINERVA MEDICA COPYRIGHT

  2004cites this paper
• Towards evidence based emergency medicine: best BETs from the Manchester Royal Infirmary

  2003cites this paper
• Outpatient treatment of acute venous thromboembolic disease.

  2003cites this paper
• [Oral anticoagulants in the elderly].

  2003cites this paper
• [Outpatient treatment of acute deep venous thrombosis of the lower limbs].

  2002cites this paper
• Traitement ambulatoire des thromboses veineuses profondes des membres inférieurs à la phase aiguë

  2002cites this paper
• Economic evaluation of the MEDENOX trial: a Canadian perspective. Medical Patients with Enoxaparin.

  2002cites this paper
• Outpatient treatment of community acquired venous thromboembolism--the Christchurch experience.

  2002cites this paper
• Outpatient treatment of deep venous thrombosis in diverse inner-city patients.

  2001cites this paper
• Heparins and Venous Thromboembolism: Current Practice and Future Directions

  2001cites this paper
• Clinical and economic aspects of managing venous thromboembolism in the outpatient setting.

  2001cites this paper
• Home treatment and secondary prevention of deep vein thrombosis.

  2001cites this paper
• Looking forward in the treatment of deep-vein thrombosis.

  2001cites this paper
• Outpatient treatment for patients with uncomplicated above knee deep vein thrombosis

  2000cites this paper
• Towards evidence based emergency medicine: best BETs from the Manchester Royal Infirmary. Outpatient treatment for patients with uncomplicated above knee deep vein thrombosis.

  2000cites this paper
• Clinical outcome and cost of hospital vs home treatment of proximal deep vein thrombosis with a low-molecular-weight heparin: the Vascular Midi-Pyrenees study.

  2000cites this paper
• [Angiology update].

  1999cites this paper
• Towards evidence based emergency medicine: best BETs from the Manchester Royal Infirmary

  1999cites this paper